Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XLIX.p

Tumor lysis syndrome (TLS)

Publications

Ripeau D, Ibarra ME, Moreno RP, Valentini L, Hernández A, Faín J, Seligra C, Tevez Echazú A, Picón A, Cardigni G

[Tumor lysis syndrome after the administration of corticosteroids in an adolescent without confirmed neoplastic disease. Case Reports].

Archivos argentinos de pediatria 2022 02;120;e49-e53 — 2022 02 — e49-e53

Buba?a H, So?ta-Jakimczyk D, Szczepa?ska M, Szprynger K

[Tumor lysis syndrome in the course of acute lymphoblastic leukemia as the consequence of prednisone monotherapy].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 2003 Aug;15;182-4 — 2003 Aug — 182-4

Wester JP, Breumelhof R, Geers AB, Meuwissen OJ

[Acute tumor lysis syndrome due to mono-therapy with a corticosteroid in a patient with non-Hodgkin lymphoma].

Nederlands tijdschrift voor geneeskunde 1997 Aug 16;141;1621-3 — 1997 Aug 16 — 1621-3